Zoetis Inc. $ZTS Shares Bought by Verdence Capital Advisors LLC

Verdence Capital Advisors LLC boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 1.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,057 shares of the company’s stock after acquiring an additional 211 shares during the period. Verdence Capital Advisors LLC’s holdings in Zoetis were worth $1,724,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ZTS. Brighton Jones LLC raised its position in Zoetis by 180.4% during the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after acquiring an additional 2,978 shares during the last quarter. Dynamic Advisor Solutions LLC acquired a new position in shares of Zoetis in the first quarter valued at approximately $1,253,000. Ritholtz Wealth Management raised its position in shares of Zoetis by 7.1% in the first quarter. Ritholtz Wealth Management now owns 21,062 shares of the company’s stock valued at $3,468,000 after buying an additional 1,400 shares during the last quarter. Aries Wealth Management acquired a new position in shares of Zoetis in the first quarter valued at approximately $226,000. Finally, Sound Income Strategies LLC raised its position in shares of Zoetis by 141.4% in the first quarter. Sound Income Strategies LLC now owns 280 shares of the company’s stock valued at $46,000 after buying an additional 164 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Stifel Nicolaus lowered shares of Zoetis from a “buy” rating to a “hold” rating and cut their price objective for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. Argus reissued a “buy” rating and issued a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Piper Sandler boosted their price objective on shares of Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Monday, August 11th. Finally, Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Four investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $196.71.

Zoetis Price Performance

Zoetis stock opened at $142.29 on Tuesday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. Zoetis Inc. has a 1 year low of $139.34 and a 1 year high of $196.55. The firm has a 50 day moving average price of $149.04 and a 200 day moving average price of $154.19. The company has a market cap of $63.06 billion, a price-to-earnings ratio of 24.49, a PEG ratio of 2.26 and a beta of 0.90.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the business earned $1.56 earnings per share. The business’s quarterly revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. Zoetis’s dividend payout ratio is presently 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.